GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Preferred Dividends

Lavipharm (ATH:LAVI) Preferred Dividends : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Lavipharm's preferred dividends for the six months ended in Jun. 2024 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.


Lavipharm Preferred Dividends Historical Data

The historical data trend for Lavipharm's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Preferred Dividends Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Preferred Dividends
Get a 7-Day Free Trial - - - - -

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Lavipharm Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Lavipharm  (ATH:LAVI) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lavipharm Business Description

Traded in Other Exchanges
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines